645 ELLIOTT AVE W STE 300 SEATTLE, WA 98119 Get Directions
645 ELLIOTT AVE W STE 300 SEATTLE, WA 98119 Get Directions
Pacific Biomarkers, Inc. (PBI) is a premier biomarker laboratory services provider in the Drug Development Industry supporting preclinical and Phase I-IV studies. Since 1989, PBI has partnered with the Pharmaceutical, Biotech and Diagnostic Manufacturing Industries to provide biomarker laboratory services. Due to these partnerships and our ability to adapt biomarkers to support compound development we have optimized study outcomes, decreased sponsors' timelines for FDA approval, and provided competitive product differentiation.
PBI has an established reputation for expertise, flexibility, protocol consultation, and outstanding client services that has propelled the company to a prominent position in the rapidly growing pharmaceutical outsourcing industry. With an extensive network of scientific, regulatory, and technology expertise, PBI is the service provider of choice for many leading international drug manufacturers in the race to bring products to market as quickly and cost effectively as possible.
PBI provides accurate, reliable analyses, and responsive service to sponsors and investigative sites. PBI collaborates with sponsors to develop, validate, improve analytical methods, and provides technical consultation for protocol design. Our services are customized on a project specific basis which allows PBI to be more flexible to meet the needs of our clients.
PBI is CAP accredited and CLIA certified. PBI also provides GLP compliant biomarker laboratory services.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.